Ralpancizumab Biosimilar – Anti-PCSK9, NARC1, PC9 mAb – Research Grade
Size | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system |
Description of Ralpancizumab Biosimilar - Anti-PCSK9/NARC1/ PC9 mAb - Research Grade
Description of Ralpancizumab Biosimilar - Anti-PCSK9/NARC1/ PC9 mAb - Research Grade
General information on Anti-PCSK9/NARC1/ PC9[Homo sapiens] (Ralpancizumab) Monoclonal Antibody
Ralpancizumab has been investigated for the treatment of Hypercholesterolemia.
Product name | Ralpancizumab Biosimilar - Anti-PCSK9, NARC1, PC9 mAb - Research Grade |
---|---|
Source | CAS 1407495-04-8 |
Species | Humanized |
Purity | >95% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Aliases /Synonyms | PF-05335810,RN317 |
Reference | PX-TA1340 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG2-kappa |
Clonality | Monoclonal Antibody |
Source | CAS 1407495-04-8 |
Product name | Ralpancizumab Biosimilar - Anti-PCSK9, NARC1, PC9 mAb - Research Grade |
---|---|
Source | CAS 1407495-04-8 |
Species | Humanized |
Expression system | Mammalian cells |
Purity | >95% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Aliases /Synonyms | PF-05335810,RN317 |
Reference | PX-TA1340 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG2-kappa |
Clonality | Monoclonal Antibody |
Source | CAS 1407495-04-8 |
Reviews
There are no reviews yet.